Debate Session: is biomarker-based cancer treatment cost-effective or a financial burden (focus: Prostate Cancer)?
Debate Session: is biomarker-based cancer treatment cost-effective or a financial burden (focus: Prostate Cancer)?
Aristotelis Bamias
Bertrand Tombal
Milos Grujic
Berardino De Bari
